You are here:
| Reference : No-Carrier-Added Regioselective Preparation of 6-[18f]Fluoro-L-Dopa |
| Scientific journals : Article | |||
| Human health sciences : General & internal medicine | |||
| http://hdl.handle.net/2268/77740 | |||
| No-Carrier-Added Regioselective Preparation of 6-[18f]Fluoro-L-Dopa | |
| English | |
| Bozet, Claire [Centre Hospitalier Universitaire de Liège - CHU > > O.R.L. >] | |
| Guillaume, Marcel [> > > >] | |
| Cantineau, R. [> > > >] | |
Christiaens, Léon  [Université de Liège - ULg > Services généraux (Faculté des sciences) > Relations académiques et scientifiques (Sciences) >] | |
| Jul-1990 | |
| Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine | |
| 31 | |
| 7 | |
| 1247-51 | |
| 0161-5505 | |
| [en] This paper describes the preparation of 6-[18F]fluoro-L-dopa by a no-carrier-added method based on the nucleophilic displacement of nitro groups of two commercially available substrates, 3,4-dimethoxy-2-nitrobenzaldehyde (nitroveratraldehyde) and 6-nitropiperonal. Fluorination was conducted in DMSO with fluorine-18 (18F) in the presence of the aminopolyether Kryptofix 222 and potassium carbonate. The condensation of the fluorinated aldehydes with phenyloxazolone and the subsequent hydrolysis with HI/P yield, after purification by HPLC, only the 6-(D, L) isomers. The racemic mixture (50/50) was resolved on an analytical scale chiral column. The method, which requires 100 min (EOB) to complete, produces 6-[18F]fluoro-L-dopa with a decay-corrected radiochemical yield of 10%, an enantiomeric purity greater than 99%, and a specific activity of 1.2 Ci/mumole. | |
| http://hdl.handle.net/2268/77740 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.
